In the ever-evolving landscape of the stock market, Fortress Biotech, Inc. has emerged as a standout performer over the past year. This company, operating within the Pharmaceuticals & Biotechnology sector, has achieved an impressive return of 73.6%. Fortress Biotech, Inc. is classified as a Micro Cap company, indicating its relatively small market capitalization compared to larger firms in the industry. This classification often attracts investors looking for high-growth potential, as smaller companies can experience significant price movements based on market dynamics and company developments. The remarkable return of Fortress Biotech, Inc. highlights its potential in the competitive pharmaceutical and biotechnology landscape. Investors and market watchers will be keen to observe how this company continues to navigate the challenges and opportunities within its sector in the coming months.